Drug name - Halaven
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6214865 | EISAI INC | Macrocyclic analogs and methods of their use and preparation |
Jul, 2023
(9 months from now) | |
| CN1312804A | EISAI INC | Macrocyclic Analogs And Methods Of Use And Preparation Method |
Jun, 2019
(3 years ago) | |
| CN1216051C | EISAI INC | Macrocyclic Analogs And Methods Of Use And Preparation Method |
Jun, 2019
(3 years ago) | |
| EP2277873A1 | EISAI INC | Intermediate Compound For The Preparation Of Halichondrin Analogs |
Jun, 2019
(3 years ago) | |
| EP2272839B1 | EISAI INC | Intermediate Compounds For The Preparation Of Halichondrin Analogs |
Jun, 2019
(3 years ago) | |
| EP2272839A1 | EISAI INC | Intermediate Compounds For The Preparation Of Halichondrin Analogs |
Jun, 2019
(3 years ago) | |
| EP2277873B1 | EISAI INC | Intermediate Compound For The Preparation Of Halichondrin Analogs |
Jun, 2019
(3 years ago) | |
| EP2272840A1 | EISAI INC | Intermediate Compound For The Preparation Of Halichondrin Analogs |
Jun, 2019
(3 years ago) | |
| EP2272840B1 | EISAI INC | Intermediate Compound For The Preparation Of Halichondrin Analogs |
Jun, 2019
(3 years ago) | |
| EP1087960B1 | EISAI INC | Macrocyclic Analogs And Methods Of Their Use And Preparation |
Jun, 2024
(1 year, 8 months from now) | |
| EP1087960A4 | EISAI INC | Macrocyclic Analogs And Methods Of Their Use And Preparation |
Jun, 2024
(1 year, 8 months from now) | |
| EP1087960A1 | EISAI INC | Macrocyclic Analogs And Methods Of Their Use And Preparation |
Jun, 2024
(1 year, 8 months from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE46965 | EISAI INC | Intermediates for the preparation of analogs of Halichondrin B |
Jan, 2027
(4 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.